- Home
- WRAP vs STRO Comparison
WRAP vs STRO Comparison
Compare WRAP & STRO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- WRAP
- STRO
- Stock Information
- Founded
- WRAP 2016
- STRO 2003
- Country
- WRAP United States
- STRO United States
- Employees
- WRAP N/A
- STRO N/A
- Industry
- WRAP Ordnance And Accessories
- STRO Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- WRAP Industrials
- STRO Health Care
- Exchange
- WRAP Nasdaq
- STRO Nasdaq
- Market Cap
- WRAP 73.3M
- STRO 69.1M
- IPO Year
- WRAP N/A
- STRO 2018
- Fundamental
- Price
- WRAP $1.42
- STRO $0.86
- Analyst Decision
- WRAP
- STRO Hold
- Analyst Count
- WRAP 0
- STRO 8
- Target Price
- WRAP N/A
- STRO $3.83
- AVG Volume (30 Days)
- WRAP 192.1K
- STRO 373.7K
- Earning Date
- WRAP 08-14-2025
- STRO 08-07-2025
- Dividend Yield
- WRAP N/A
- STRO N/A
- EPS Growth
- WRAP N/A
- STRO N/A
- EPS
- WRAP N/A
- STRO N/A
- Revenue
- WRAP $3,236,000.00
- STRO $104,473,000.00
- Revenue This Year
- WRAP N/A
- STRO N/A
- Revenue Next Year
- WRAP N/A
- STRO N/A
- P/E Ratio
- WRAP N/A
- STRO N/A
- Revenue Growth
- WRAP N/A
- STRO N/A
- 52 Week Low
- WRAP $1.20
- STRO $0.52
- 52 Week High
- WRAP $2.58
- STRO $5.17
- Technical
- Relative Strength Index (RSI)
- WRAP 51.98
- STRO 54.56
- Support Level
- WRAP $1.26
- STRO $0.81
- Resistance Level
- WRAP $1.44
- STRO $0.83
- Average True Range (ATR)
- WRAP 0.10
- STRO 0.07
- MACD
- WRAP 0.01
- STRO 0.01
- Stochastic Oscillator
- WRAP 62.86
- STRO 48.90
About WRAP Wrap Technologies Inc.
Wrap Technologies Inc is a public safety technology and services company that delivers safe and effective policing solutions to law enforcement and security personnel worldwide. The firm develops policing solutions to law enforcement and security personnel. Its BolaWRAP 150 Remote Restraint device is a patented, hand-held tool that discharges a Kevlar cord to restrain noncompliant individuals from a range of 10-25 feet. The group operates in the Americas, Europe, the Middle East, Africa and the Asia Pacific.
About STRO Sutro Biopharma Inc.
Sutro Biopharma Inc is a clinical-stage drug discovery, development, and manufacturing company. It is mainly engaged in the development of biopharmaceutical products. The company manufactures next-generation protein therapeutics for cancer and autoimmune disorders through its proprietary integrated cell-free protein synthesis platform, XpressCF. Products offered by the company include STRO-001 for patients with multiple myeloma and non-Hodgkin lymphoma and STRO-002 for the treatment of ovarian and endometrial cancers. The company also pipeline contains STRO-004, STRO-006, STRO-00X, STRO-00Y, STRO-003, VAX24, VAX31, and Others.